Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a …

S Amadori, S Suciu, R Stasi, HR Salih… - Journal of clinical …, 2013 - ascopubs.org
Purpose This randomized trial evaluated the efficacy and toxicity of sequential gemtuzumab
ozogamicin (GO) and standard chemotherapy in older patients with newly diagnosed acute …
被引用次数：94 相关文章

Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a …

S Amadori, S Suciu, R Stasi… - Journal of clinical …, 2013 - repository.uantwerpen.be
Purpose This randomized trial evaluated the efficacy and toxicity of sequential gemtuzumab
ozogamicin (GO) and standard chemotherapy in older patients with newly diagnosed acute …

[引用][C] Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results …

S Amadori, S Suciu, R Stasi, HR Salih… - Journal of Clinical …, 2013 - ub01.uni-tuebingen.de
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older
Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III …
[PDF] researchgate.net

[PDF][PDF] Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results …

S Amadori, S Suciu, R Stasi, HR Salih, D Selleslag… - 2013 - researchgate.net
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older
Patients With Newly Diagnosed Acute Myeloid L Page 1 Sequential Combination of …

[引用][C] Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a …

S Amadori, S Suciu, R Stasi, H Salih… - JOURNAL OF …, 2013 - ricerca.uniba.it
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older
patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by …

Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: Results of a …

S Amadori, S Suciu, R Stasi, H Salih… - JOURNAL OF …, 2013 - art.torvergata.it
Purpose This randomized trial evaluated the efficacy and toxicity of sequential gemtuzumab
ozogamicin (GO) and standard chemotherapy in older patients with newly diagnosed acute …

[引用][C] Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results …

S Amadori, S Suciu, R Stasi, HR Salih, D Selleslag… - 2013 - repository.ubn.ru.nl
PURPOSE: This randomized trial evaluated the efficacy and toxicity of sequential
gemtuzumab ozogamicin (GO) and standard chemotherapy in older patients with newly …

[引用][C] Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results …

S Amadori, S Suciu, R Stasi… - Journal of …, 2013 - scholarlypublications …
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older
Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III …

Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a …

S Amadori, S Suciu, R Stasi, H Salih… - JOURNAL OF …, 2013 - iris.uniroma1.it
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older
patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial …

Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a …

S Amadori, S Suciu, R Stasi, HR Salih… - Journal of Clinical …, 2013 - europepmc.org
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older
patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial …